{
  "ptid_time": "012_S_5213_2013-07-10",
  "img_path": "/data/qiuhui/data/adni/images/012_S_5213/2013-07-10/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 8,441 mm³, 62.2% below the reference mean. With a Z-score of -1.56 (6.0th percentile), this represents moderate atrophy; hippocampal volume measures 6,640 mm³, 13.6% below the reference mean. With a Z-score of -1.53 (6.4th percentile), this represents moderate atrophy; whole brain volume measures 930,192 mm³, 9.6% below the reference mean. With a Z-score of -1.20 (11.6th percentile), this represents mild atrophy; entorhinal cortex volume measures 3,116 mm³, 20.0% below the reference mean. With a Z-score of -1.55 (6.1th percentile), this represents moderate atrophy; fusiform gyrus volume measures 17,553 mm³, 3.6% below the reference mean. With a Z-score of -0.41 (34.2th percentile), this represents normal volume ; middle temporal gyrus volume measures 16,331 mm³, 20.4% below the reference mean. With a Z-score of -1.81 (3.5th percentile), this represents moderate atrophy. ",
  "text_data": "Age is 65.4 years. Gender is Female. Education: 16 years. MMSE: 28.0. MoCA: 29.0. Logical Memory: 16.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.02 SUVR (normal ); Total tau: 298.30 pg/mL (normal ); Phosphorylated tau: 25.87 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows moderate atrophy in key Alzheimer's-related regions (hippocampus, entorhinal cortex, middle temporal gyrus) alongside mild whole-brain atrophy, suggesting neurodegenerative changes. However, cognitive scores (MMSE 28, MoCA 29) are intact, and biomarkers (tau, amyloid) are normal, making early AD unlikely.  \n**Diagnosis:** **MCI** (structural changes precede cognitive decline, but biomarkers are normal; could represent non-AD etiology).  \n**Confidence:** **Medium** (discrepancy between imaging and clinical/biomarker data warrants caution).  \n\n**Key Points:**  \n- Atrophy in AD-vulnerable regions is concerning but not specific without amyloid/tau support.  \n- Intact cognition rules out dementia; MCI is plausible if subtle symptoms exist (not captured here).  \n- APOE4-negative status and normal biomarkers lower AD likelihood; consider other neurodegenerative or vascular causes.  \n\n**Alternative:** If cognitive testing missed subtle deficits, **prodromal AD** is possible, but biomarker normality makes this less likely. Follow-up with longitudinal cognitive/imaging assessments is recommended.",
  "timestamp": "2025-07-25T23:18:49.083348"
}